Price: $ 1295
BMI View: The 2012-2017 forecast period is likely to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines market, which will increasingly attract prominent international players in the field, as well as prompt local companies to get more involved in the segment. Headline Expenditure Projections ? Pharmaceuticals: CHF6.58bn (US$7.02bn) in 2012 to CHF6.30bn (US$6.13bn) in 2013; -4.3% decline in local currency terms. ? Healthcare: CHF64.86bn (US$68.18bn) in 2012 to CHF66.11bn (US$64.38bn) in 2013; +1.9% growth in local currency terms. ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/278760.html
No comments:
Post a Comment